Stockhead TV
Check out the latest Medical Cannabis news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
Here’s how Australia offers a strong operating environment for cannabis biotech stocks
Health & Biotech
Medicinal cannabis manufacturing becomes a key focus for WA
Health & Biotech
CannPal closes quarter with cash and commercialisation plans
Health & Biotech
Health Kick Podcast: Botanix is using synthetic cannabinoids to treat acne and other skin conditions
Health & Biotech
Experts: How to position for the next wave in cannabis
Health & Biotech
Australia’s cannabis sector is finally maturing
Health & Biotech
CannPal’s doggie drug DermaCann tackles atopic dermatitis
Health & Biotech
MGC Pharma expands footprint with cannabis clinic acquisition
Health & Biotech
Is Compass Cannabis your next ASX pot stock?
Health & Biotech
These are the ‘watershed’ reforms ASX cannabis investors should look out for
Health & Biotech
MGC Pharma receives Australian cannabis research permit
Health & Biotech
Pot stock Zelira Therapeutics successfully passes another Phase I clinical trial
Health & Biotech
Creso Pharma wins second Israeli order for its medicinal cannabis
Health & Biotech
Bod makes $2.5m from Aussie pot buyers in the June quarter alone
Health & Biotech
MGC Pharma lands US buyer for the $8.5m sale of its Nutraceuticals business
Health & Biotech
MGC Pharma scoops major Israeli partnership for epilepsy drug
Health & Biotech
No marijuana is ok for pregnant women, not even for morning sickness
Health & Biotech
eSense shifts gears into cosmeceuticals with Aussie tie-up
Health & Biotech
User growth is still climbing, but a price war may be heating up in Australia’s cannabis market
Health & Biotech
Creso Pharma’s Canadian retail sales set to start
Health & Biotech
Weed Week: Moves are afoot in the US to fix a cannabis ‘scheduling’ clash
Health & Biotech
Creso Pharma’s South Africa sales begin with Cannamics
Health & Biotech
Creso is perfectly poised for growth in the huge Brazilian market
Health & Biotech
Weed Week: Cannabis for kids? UK baby participates in world-first treatment
Health & Biotech
THC Global starts sales as one of few pot stocks making Aussie-grown marijuana
Health & Biotech
Struggling coal mining town Collie is WA govt’s choice for new hemp processing plant
Health & Biotech
TGA may make CBD legal in pharmacies this year
News
MGC Pharma scores new trial approval from major Israeli hospital for COVID-19 treatment
Health & Biotech
Weed Week: Asking the big questions – what takes priority in a pandemic, cannabis or toilet paper?
Health & Biotech
Creso Pharma continues global distribution push with new strategic partnership into Pakistan
Health & Biotech
Avecho finds a new use for its drug delivery technology in the pot market
Health & Biotech
Health Kick Podcast: Increasing athletic performance and fighting sleep apnea with a simple nose clip
Health & Biotech
Creso Pharma’s latest anibidiol shipment to Virbac makes over $200k in revenue
Health & Biotech
Zelira, PolyNovo prove even a pandemic can’t stand in the way of good clinical results
Health & Biotech
Creso Pharma breaks into lucrative Israeli market, streaks past 2019 revenues
Health & Biotech
Will COVID-19 impact pot stocks? Depends on what part of the industry you’re in
Health & Biotech
Some Aussie pharmacists can sell medicines without a script, possibly even cannabis
Health & Biotech
Dr Boreham’s Crucible: Zelira’s share price could wake up once sales of its pot-based insomnia drug start
Health & Biotech
MMJ Holdings stays flexible on capital strategy, offers improved terms to investors
Health & Biotech
Two ex-Canopy Growth top guns join Creso’s Mernova team
News
Weed Week: COVID-19 drags on sentiment as ASX-listed pot stocks go 0/33
Food & Agriculture
Health Kick Podcast: The strategy and upside behind global cannabis investment company MMJ
Health & Biotech
The outlook is sunny for Harvest One Cannabis and its biggest investor, MMJ Group
Health & Biotech
Ace in the hole: MMJ Group’s direct exposure to the huge North American cannabis market is poised to pay dividends
Health & Biotech
MGC Pharma drives home Brazil advantage with lucrative seven-year supply agreement
Health & Biotech
Who says cannabis is cactus? These analysts reckon 2020 is the year of the green stuff
Health & Biotech
Cannabis: Impression Healthcare is testing its cannabinoid formula against brain injuries
Load More
